...
首页> 外文期刊>Ultrasound in Medicine and Biology >Therapeutic ultrasonic microbubbles carrying paclitaxel and LyP-1 peptide: preparation, characterization and application to ultrasound-assisted chemotherapy in breast cancer cells.
【24h】

Therapeutic ultrasonic microbubbles carrying paclitaxel and LyP-1 peptide: preparation, characterization and application to ultrasound-assisted chemotherapy in breast cancer cells.

机译:携带紫杉醇和LyP-1肽的治疗性超声微泡:在乳腺癌细胞中进行超声辅助化学疗法的制备,表征和应用。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this work was to develop a novel targeted drug-loaded microbubble (MB) and to investigate its chemotherapy effect in vitro. Paclitaxel (PTX)-loaded lipid MBs were prepared by a mechanical vibration technique. The LyP-1, a breast tumor homing peptide, was coated onto the surface of PTX-loaded MBs through biotin-avidin linkage. The resulting targeted drug-loaded MBs were characterized and applied to ultrasound-assisted chemotherapy in breast cancer cells. Our results showed the ultrasonic MBs were able to achieve 43%-63% of drug encapsulation efficiency, depending on drug loading amount. The binding affinity assay indicated the attachment of targeted MBs to human MDA-MB-231 breast cancer cells was highly efficient and stable even with ultrasonic irradiation on. The cellular uptake efficiency of payload in targeted MBs was 3.71-, 4.95-, 7.43- and 7.66-fold higher than that of non-targeted MBs at the applied ultrasound time of 30, 60, 90 and 120 s, respectively. In addition, the cell proliferation inhibition assay showed the cell viability of targeted PTX-loaded MBs was significantly lower than that of non-targeted PTX-loaded MBs and non-targeted unloaded MBs when ultrasound was utilized. In conclusion, the study indicated the LyP-1-coated PTX-loaded MBs significantly increased the antitumor efficacy and can be used as a potential chemotherapy approach for ultrasound-assisted breast cancer treatment.
机译:这项工作的目的是开发一种新型的靶向载药微泡(MB),并研究其体外化学疗法的作用。通过机械振动技术制备负载紫杉醇(PTX)的脂质MB。 LyP-1是一种乳腺肿瘤归巢肽,通过生物素-亲和素连接被包被到PTX负载的MBs表面。表征所得的靶向载药MB,并将其应用于乳腺癌细胞中的超声辅助化学疗法。我们的结果表明,超声波MBs能够达到43%-63%的药物包封效率,具体取决于载药量。结合亲和力测定表明,即使在超声照射下,靶向MBs对人MDA-MB-231乳腺癌细胞的附着也是高效且稳定的。在施加超声时间分别为30、60、90和120 s时,目标MB的有效载荷对细胞的吸收效率分别比非目标MB高3.71倍,4.95倍,7.43倍和7.66倍。此外,细胞增殖抑制试验显示,当使用超声时,靶向PTX负载的MBs的细胞活力显着低于非靶向PTX负载的MB和非靶向卸载的MB。总之,该研究表明,LyP-1涂层的PTX负载的MBs显着提高了抗肿瘤功效,可作为超声辅助乳腺癌治疗的潜在化学疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号